Preview

Колопроктология

Расширенный поиск

ФАКТОРЫ РИСКА РАЗВИТИЯ ДИАРЕИ, АССОЦИИРОВАННОЙ С ŒOSTRIDIUM DIFFICILE, У КОЛОПРОКТОЛОГИЧЕСКИХ БОЛЬНЫХ (обзор литературы)

https://doi.org/10.33878/2073-7556-2017-0-1-59-67

Полный текст:

Об авторах

А. Л. Сафин
ФГБУ «ГНЦК им. А.Н.Рыжих» Минздрава России
Россия


С. И. Ачкасов
ФГБУ «ГНЦК им. А.Н.Рыжих» Минздрава России
Россия


М. А. Сухина
ФГБУ «ГНЦК им. А.Н.Рыжих» Минздрава России
Россия


О. И. Сушков
ФГБУ «ГНЦК им. А.Н.Рыжих» Минздрава России
Россия


Список литературы

1. Пилиев Д.В., Ачкасов С.И., Корнева Т.К. и соавт. Антибиотикоассоциированная диарея: современное состояние проблемы. Российский Журнал Гастроэнтерологии, Гепатологии, Колопроктологии. - 2014. - № 5. - с. 54-61.

2. Пикунов Д.Ю., Рыбаков Е.Г. и соавт. Псевдомембранозный колит (обзор литературы). Колопроктология. - 2010. - №2 (32). - с. 55-60.

3. Шелыгин Ю.А., Головенко О.В., Головенко А.О. и соавт. Трансплантация фекальной микробиоты - перспективы применения при заболеваниях кишечника (обзор литературы). Колопроктология. - 2015. - №4 (54). - с. 65-73.

4. Abdelsattar Z.M. et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection. Infection Control & Hospital Epidemiology. - 2015. -№1 (36). - p. 40-46.

5. Abou Chakrap N. et al. Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. - 2015. - №12 (61). -p. 1781-8.

6. Ahmetagic S. et al. Clostridium difficile infection in hospitalized patients at university clinical center tuzla, bosnia and herzegovina: a 4 year experience. Materia socio-medica. - 2013. - №3 (25). - p. 153-7.

7. Alicinop et al. Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population. Epidemiology and infection. - 2016. - №12 (144). - p. 2517-26.

8. Angarone M., Ison M.G. Diarrhea in solid organ transplant recipients. Current opinion in infectious diseases. - 2015. - №4 (28). - p. 308-16.

9. Aquinap.T. et al. High Variability in Nosocomial Clostridium difficile Infection Rates Across Hospitals After Colorectal Resection. Diseases of the Colon & Rectum. - 2016. - №4 (59). - p. 323-331.

10. Bartlett J.G. Historical perspectives on studies of Clostridium difficile andp. difficile infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. - 2008. -Supplement 1 (46 Suppl 1). - p. S4-11.

11. Bartlett J.G., Onderdonk A.B., Cisneros R.L. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology. - 1977. - № 4 Pt 1 (73). - p. 772-6.

12. Buonomo E.L., Petri W.A. The microbiota and immune response during Clostridium difficile infection. Anaerobe. - 2016. (41). - p. 79-84.

13. Clements A.C. et al. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. The Lancet Infectious Diseases. - 2010. -№6 (10). - p. 395-404.

14. Cohen S.H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology. -2010. - №5 (31). - p. 431-455.

15. Dave M. et al. Opportunistic Infections Due to Inflammatory Bowel Disease Therapy. Inflammatory Bowel Diseases. - 2014. - №1 (20). - p. 196-212.

16. Deshpande A. et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infection control and hospital epidemiology. - 2015. - №4 (36). - p. 452-60.

17. Eichel-Streiberp et al. Morphological changes in adherent cells induced by Clostridium difficile toxins. Biochemical Society transactions. - 1991. - №4 (19). -p. 1154-60.

18. Eliakim-Raz N. et al. Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. - 2015. -№6 (34). - p. 1201-5.

19. Goudarzi M. et al. Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica. - 2014. (2014). p. 916826.

20. Guo S. et al. The recombinant Lactococcus lactis oral vaccine induces protection againstp. difficile spore challenge in a mouse model. Vaccine. - 2015. -№13 (33). - p. 1586-1595.

21. Hainesp F. et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (London, England). - 2013. -№17 (27). - p. 2799-807.

22. Hashash J.G., Binion D.G. Managing Clostridium difficile in inflammatory bowel disease (IBD). Current gastroenterology reports. - 2014. - №7 (16). - p. 393.

23. Hensgens M.P.M. et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. The Journal of antimicrobial chemotherapy. - 2012. - №3 (67). - p. 742-8.

24. Huang H. et al. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. - 2014. (30). p. 65-69.

25. Johnson S. et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. The American Journal of Medicine. - 1990. - №2 (88). - p. 137-140.

26. Kim J. et al. Epidemiology and Clinical Characteristics of Clostridium difficile Infection in a Korean Tertiary Hospital. Journal of Korean Medical Science. - 2011. - №10 (26). - p. 1258.

27. Kim J.W. et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World Journal of Gastroenterology. - 2010. - №28 (16). - p. 3573-7.

28. Kundrapu S. et al. A Randomized Trial of Soap and Water Hand Wash Versus Alcohol Hand Rub for Removal of Clostridium difficile Spores from Hands of Patients. Infection Control & Hospital Epidemiology. - 2014. - №2 (35). - p. 204-206.

29. Landellep et al. Contamination of Healthcare Workers’ Hands with Clostridium difficile Spores after Caring for Patients with difficile Infection. Infection Control & Hospital Epidemiology. - 2014. - №1 (35). -p. 10-15.

30. Larson H.E. et al. Undescribed toxin in pseudomembranous colitis. BMJ. - 1977. - № 6071 (1).

31. Lee H.C. et al. Clinical Outcomes in Hospitalized Patients with Clostridium difficile Infection by Age Group. The Korean Journal of Gastroenterology. - 2016. - №2 (67). - p. 81.

32. Levin J. et al. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. - 2013.

33. MacLaren R. et al. Histamine-2 Receptor Antagonists vs Proton Pump Inhibitors on Gastrointestinal Tract Hemorrhage and Infectious Complications in the Intensive Care Unit. JAMA Internal. Medicine. - 2014. - №4 (174). - p. 564.

34. McFarland L.V., Surawiczp M. Clostridium Difficile Associated Disease: Diagnosis and Treatment Oxford, UK: Wiley-Blackwell. - 2010. p. 335-354.

35. Pépin J. et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. - 2004. - №5 (171). - p. 466-72.

36. Phatharacharukul P. et al. The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. - 2015. - №10 (60). - p. 2913-2922.

37. Potter V.A., Aravinthan A. Identifying patients at risk of severe Clostridium difficile-associated disease. British Journal of Hospital Medicine (London, England: 2005). - 2012. - №5 (73). - p. 265-70.

38. Qu H.-Q., Jiang Z.-D. Clostridium difficile infection in diabetes. Diabetes research and clinical practice. - 2014. - №3 (105). p. 285-94.

39. Rodriguezp et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014. (30). - p. 184-187.

40. Schneeweiss S. et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Alimentary Pharmacology & Therapeutics. - 2009. - №3 (30). - p. 253-264.

41. Skricka T. et al. Клостридиальный колит - важная проблема в хирургии. Колопроктология. -2014. - №4 (50). - p. 17-23.

42. Steindl G. et al. Effect of airborne hydrogen peroxide on spores of Clostridium difficile. Wiener klinische Wochenschrift. - 2015. - №11-12 (127). -p. 421-426.

43. Surawiczp.M. et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. The American Journal of Gastroenterology. - 2013. - №4 (108). - p. 478-498.

44. Vesoulis Z., Williams G., Matthews B. Pseudomembranous enteritis after proctocolectomy. Diseases of the Colon & Rectum. - 2000. - №4 (43). -p. 551-554.

45. Zhang T. et al. Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease. Scientific reports. - 2016. (6). - p. 29791.


Для цитирования:


Сафин А.Л., Ачкасов С.И., Сухина М.А., Сушков О.И. ФАКТОРЫ РИСКА РАЗВИТИЯ ДИАРЕИ, АССОЦИИРОВАННОЙ С ŒOSTRIDIUM DIFFICILE, У КОЛОПРОКТОЛОГИЧЕСКИХ БОЛЬНЫХ (обзор литературы). Колопроктология. 2017;(1):59-67. https://doi.org/10.33878/2073-7556-2017-0-1-59-67

For citation:


Safin A.L., Achkasov S.I., Sukhina M.A., Sushkov O.I. RISK FACTORS FOR DIARRHEA ASSOCIATED WITH CLOSTRIDIUM DIFFICILE, IN COLOPROCTOLOGICAL PATIENTS (review). Koloproktologia. 2017;(1):59-67. (In Russ.) https://doi.org/10.33878/2073-7556-2017-0-1-59-67

Просмотров: 79


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)